We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FALSE CLAIMS ACT POPULAR FOR OFF-LABEL USE PROMOTIONS
FALSE CLAIMS ACT POPULAR FOR OFF-LABEL USE PROMOTIONS
January 23, 2004
Drugmakers involved in potential off-label promotions of their products need to be wary of a new tactic used by prosecutors that has greater financial consequences than FDA enforcement activities under the Food, Drug and Cosmetic Act: prosecution under the False Claims Act.